These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 17084625

  • 21. A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
    Labrie F, Martel C.
    Horm Mol Biol Clin Investig; 2017 Feb 01; 29(2):39-60. PubMed ID: 27997350
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey.
    Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F.
    J Steroid Biochem Mol Biol; 2002 Jun 01; 81(2):159-64. PubMed ID: 12137806
    [Abstract] [Full Text] [Related]

  • 23. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G.
    Clin Endocrinol (Oxf); 2013 Nov 01; 79(5):716-24. PubMed ID: 23488643
    [Abstract] [Full Text] [Related]

  • 24. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S, Massien C, Lahlou N, Roger M, Debuire B, Diquet B, Chatellier G, Azizi M, Faucounau V, Porchet H, Forette F, Baulieu EE.
    J Clin Endocrinol Metab; 2000 Sep 01; 85(9):3208-17. PubMed ID: 10999810
    [Abstract] [Full Text] [Related]

  • 25. Concentration range of serum sex steroids in normal postmenopausal women and those with diagnosis of vulvovaginal atrophy.
    Ke Y, Bélanger A, Simard JN, Gonthier R, Martel C, Vaillancourt M, Labrie F.
    Menopause; 2018 Mar 01; 25(3):293-300. PubMed ID: 29206779
    [Abstract] [Full Text] [Related]

  • 26. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency.
    Morales A, Black A, Emerson L, Barkin J, Kuzmarov I, Day A.
    Aging Male; 2009 Dec 01; 12(4):104-12. PubMed ID: 19883295
    [Abstract] [Full Text] [Related]

  • 27. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N, Ninni F, Stomati M, Freschi L, Casarosa E, Valentino V, Luisi S, Genazzani AD, Potì E, Genazzani AR.
    Maturitas; 2008 Apr 20; 59(4):293-303. PubMed ID: 18394829
    [Abstract] [Full Text] [Related]

  • 28. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey.
    Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F.
    J Clin Endocrinol Metab; 2003 Sep 20; 88(9):4293-302. PubMed ID: 12970301
    [Abstract] [Full Text] [Related]

  • 29. Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts.
    Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, Nawata H.
    Mech Ageing Dev; 2002 Apr 30; 123(8):1107-14. PubMed ID: 12044960
    [Abstract] [Full Text] [Related]

  • 30. Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women.
    Rubino S, Stomati M, Bersi C, Casarosa E, Luisi M, Petraglia F, Genazzani AR.
    Maturitas; 1998 Jan 12; 28(3):251-7. PubMed ID: 9571601
    [Abstract] [Full Text] [Related]

  • 31. Science of intracrinology in postmenopausal women.
    Labrie F, Bélanger A, Pelletier G, Martel C, Archer DF, Utian WH.
    Menopause; 2017 Jun 12; 24(6):702-712. PubMed ID: 28098598
    [Abstract] [Full Text] [Related]

  • 32. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep 12; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 33. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F, Luu-The V, Labrie C, Simard J.
    Front Neuroendocrinol; 2001 Jul 12; 22(3):185-212. PubMed ID: 11456468
    [Abstract] [Full Text] [Related]

  • 34. Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women.
    Hirshman E, Merritt P, Wang CC, Wierman M, Budescu DV, Kohrt W, Templin JL, Bhasin S.
    Horm Behav; 2004 Feb 12; 45(2):144-55. PubMed ID: 15019802
    [Abstract] [Full Text] [Related]

  • 35. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
    Labrie F.
    J Steroid Biochem Mol Biol; 2015 Jan 12; 145():133-8. PubMed ID: 24923731
    [Abstract] [Full Text] [Related]

  • 36. A rapid and sensitive UPLC-MS/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3α, 17β diol 17-glucuronide in postmenopausal women.
    Ke Y, Gonthier R, Isabelle M, Bertin J, Simard JN, Dury AY, Labrie F.
    J Steroid Biochem Mol Biol; 2015 May 12; 149():146-52. PubMed ID: 25701608
    [Abstract] [Full Text] [Related]

  • 37. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K, Neuenschwander PF, Kurdowska AK.
    Int J Pharm Compd; 2013 May 12; 17(1):74-85. PubMed ID: 23627249
    [Abstract] [Full Text] [Related]

  • 38. Steroid metabolism and profile of steroidogenic gene expression in Episkin: high similarity with human epidermis.
    Luu-The V, Ferraris C, Duche D, Bélanger P, Leclaire J, Labrie F.
    J Steroid Biochem Mol Biol; 2007 Oct 12; 107(1-2):30-6. PubMed ID: 17662597
    [Abstract] [Full Text] [Related]

  • 39. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women.
    Portman DJ, Labrie F, Archer DF, Bouchard C, Cusan L, Girard G, Ayotte N, Koltun W, Blouin F, Young D, Wade A, Martel C, Dubé R, other participating members of VVA Prasterone Group.
    Menopause; 2015 Dec 12; 22(12):1289-95. PubMed ID: 25968836
    [Abstract] [Full Text] [Related]

  • 40. Dhea supplementation and cognition in postmenopausal women.
    Parsons TD, Kratz KM, Thompson E, Stanczyk FZ, Buckwalter JG.
    Int J Neurosci; 2006 Feb 12; 116(2):141-55. PubMed ID: 16393880
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.